Therapy-related acute myeloid leukaemia with mutated NPM1:: treatment induced or de novo in origin?

被引：14

作者：

Falini, B. ^{[1
]}

机构：

[1] Univ Perugia, Inst Haematol, Sect Haematol & Immunol, I-06100 Perugia, Italy

来源：

LEUKEMIA | 2008年 / 22卷 / 05期

关键词：

D O I：

10.1038/leu.2008.44

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：891 / 892

页数：2

共 16 条

[1] Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+ AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance [J].

Alcalay, M ;

Tiacci, E ;

Bergomas, R ;

Bigerna, B ;

Venturini, E ;

Minardi, SP ;

Meani, N ;

Diverio, D ;

Bernard, L ;

Tizzoni, L ;

Volorio, S ;

Luzi, L ;

Colombo, E ;

Lo Coco, F ;

Mecucci, C ;

Falini, B ;

Pelicci, PG .

BLOOD, 2005, 106 (03) :899-902

[2]

ANDERSEN MT, 2008, LEUKEMIA

[3] Internal tandem duplications of the FLT3 and MLL genes are mainly observed in atypical cases of therapy-related acute myeloid leukemia with a normal karyotype and are unrelated to type of previous therapy [J].

Christiansen, DH ;

Pedersen-Bjergaard, J .

LEUKEMIA, 2001, 15 (12) :1848-1851

[4] Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics:: interaction with other gene mutations [J].

Döhner, K ;

Schlenk, RF ;

Habdank, M ;

Scholl, C ;

Rücker, FG ;

Corbacioglu, A ;

Bullinger, L ;

Fröhling, S ;

Döhner, H .

BLOOD, 2005, 106 (12) :3740-3746

[5] Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. [J].

Falini, B ;

Mecucci, C ;

Tiacci, E ;

Alcalay, M ;

Rosati, R ;

Pasqualucci, L ;

La Starza, R ;

Diverio, D ;

Colombo, E ;

Santucci, A ;

Bigerna, B ;

Pacini, R ;

Pucciarini, A ;

Liso, A ;

Vignetti, M ;

Fazi, P ;

Meani, N ;

Pettirossi, V ;

Saglio, G ;

Mandelli, F ;

Lo-Coco, F ;

Pelicci, P ;

Martelli, MF .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (03) :254-266

[6] Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML):: biologic and clinical features [J].

Falini, Brunangelo ;

Nicoletti, Ildo ;

Martelli, Massimo F. ;

Mecucci, Cristina .

BLOOD, 2007, 109 (03) :874-885

[7] Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML [J].

Falini, Brunangelo ;

Bolli, Niccolò ;

Shan, Jing ;

Martelli, Maria Paola ;

Liso, Arcangelo ;

Pucciarini, Alessandra ;

Bigerna, Barbara ;

Pasqualucci, Laura ;

Mannucci, Roberta ;

Rosati, Roberto ;

Gorello, Paolo ;

Diverio, Daniela ;

Roti, Giovanni ;

Tiacci, Enrico ;

Cazzaniça, Giovanni ;

Biondi, Andrea ;

Schnittger, Suzanne ;

Haferlach, Torsten ;

Hiddemann, Wolfgang ;

Martelli, Massimo F. ;

Gu, Wei ;

Mecucci, Cristina ;

Nicoletti, Ildo .

BLOOD, 2006, 107 (11) :4514-4523

[8] DNA topoisomerase II in therapy-related acute promyelocytic leukemia [J].

Mistry, AR ;

Felix, CA ;

Whitmarsh, RJ ;

Mason, A ;

Reiter, A ;

Cassinat, B ;

Parry, A ;

Walz, C ;

Wiemels, JL ;

Segal, MR ;

Adès, L ;

Blair, IA ;

Osheroff, N ;

Peniket, AJ ;

Lafage-Pochitaloff, M ;

Cross, NCP ;

Chomienne, C ;

Solomon, E ;

Fenaux, P ;

Grimwade, D .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (15) :1529-1538

[9] Pediatric acute myeloid leukemia with NPM1 mutations is characterized by a gene expression profile with dysregulated HOX gene expression distinct from MLL-rearranged leukemias [J].

Mullighan, C. G. ;

Kennedy, A. ;

Zhou, X. ;

Radtke, I. ;

Phillips, L. A. ;

Shurtleff, S. A. ;

Downing, J. R. .

LEUKEMIA, 2007, 21 (09) :2000-2009

[10]

PASQUALUCCI L, 2008, LEUKEMIA

← 1 2 →